NCT02681562 2016-02-15Olaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer PatientsIstituti Ospitalieri di CremonaPhase 2 Unknown45 enrolled